
handle: 11181/3428
El lupus afecta a menos de 20.000 personas en España, por lo que es considerada como una “enfermedad rara”, aunque sea la “menos rara” de las más de 6.000 catalogadas. Los grandes laboratorios farmacéuticos se centran en soluciones a problemas que afecten a mayor número de personas, por lo que las universidades parecen ser el último recurso para investigar este tipo de afecciones cuyos tratamientos no parecen ser excesivamente rentables.
Tratamiento médico, Enfermedades dermatológicas, Diagnóstico, Discapacidad, Lupus, Enfermedades crónicas, Síntomas
Tratamiento médico, Enfermedades dermatológicas, Diagnóstico, Discapacidad, Lupus, Enfermedades crónicas, Síntomas
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
